Lupus pregnancy: Is heparin a risk factor for osteoporosis?

Lupus

Volumn 10, Issue 9, 2001, Pages 597-600

  Ruiz Irastorza, G ^a   Khamashta, M A ^a   Nelson Piercy, C ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticoagulants; Antiphospholipid; Miscarriage; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM; CORTICOSTEROID; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN; VITAMIN D;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BONE ATROPHY; BREAST FEEDING; CALCIUM HOMEOSTASIS; CORTICOSTEROID THERAPY; DRUG INDICATION; FEMALE; HUMAN; LACTATION; OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VERTEBRA FRACTURE;

ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 0034787952     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301682430168     Document Type: Review

References (32)

1. The management of thrombosis in the antiphospholipid-antibody syndrome
2. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes syndrome
3. Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: Maternal and fetal complications and their management
4. Low-molecular-weight heparins
5. Calcium metabolism during pregnancy and lactation
6. Pregnancy-associated osteoporosis
7. Heparin-induced osteoporosis
8. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy
9. Pregnancy-associated osteoporosis
10. Pregnancy-associated osteoporosis: Does the skeleton recover?
11. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
12. A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats
13. Use of antithrombotic agents during pregnancy
14. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin® in patients with venous thromboembolism and contraindications to coumarin)
15. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
16. Heparin effect on bone density
17. The effects of long-term heparin therapy during pregnancy on bone density: A prospective matched controlled study
18. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
19. Bone mineral density during long-term prophylaxis with heparin in pregnancy
20. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
21. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies
22. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
23. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid-related fetal loss
24. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
25. Safety of low-molecular-weight heparin in pregnancy: A systematic review
26. Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies
27. Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
28. Use of low molecular weight heparin in pregnancy
29. Bone density studies in pregnant women receiving heparin
30. Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium
31. Systemic lupus erythematosus
32. Antiphospholipid syndrome in pregnancy: A controlled treatment trial